| Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma EO Vik-Mo, M Nyakas, BV Mikkelsen, MC Moe, P Due-Tønnesen, ... Cancer Immunology, Immunotherapy 62, 1499-1509, 2013 | 293 | 2013 |
| Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model H Almåsbak, E Walseng, A Kristian, MR Myhre, EM Suso, LA Munthe, ... Gene therapy 22 (5), 391-403, 2015 | 138 | 2015 |
| Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001 EM Inderberg-Suso, S Trachsel, K Lislerud, AM Rasmussen, ... Oncoimmunology 1 (5), 670-686, 2012 | 137 | 2012 |
| hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes EMI Suso, S Dueland, AM Rasmussen, T Vetrhus, S Aamdal, G Kvalheim, ... Cancer Immunology, Immunotherapy 60, 809-818, 2011 | 116 | 2011 |
| CD8 T cell help for innate antitumor immunity A Shanker, G Verdeil, M Buferne, EM Inderberg-Suso, D Puthier, F Joly, ... The Journal of Immunology 179 (10), 6651-6662, 2007 | 112 | 2007 |
| A TCR-based chimeric antigen receptor E Walseng, H Köksal, IM Sektioglu, A Fåne, G Skorstad, G Kvalheim, ... Scientific reports 7 (1), 10713, 2017 | 99 | 2017 |
| Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy TA Theodossiou, M Ali, M Grigalavicius, B Grallert, P Dillard, KO Schink, ... NPJ breast cancer 5 (1), 13, 2019 | 97 | 2019 |
| Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer W Lilleby, G Gaudernack, PF Brunsvig, L Vlatkovic, M Schulz, K Mills, ... Cancer Immunology, Immunotherapy 66, 891-901, 2017 | 92 | 2017 |
| T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling SE Josefsson, K Huse, A Kolstad, K Beiske, D Pende, CB Steen, ... Clinical Cancer Research 24 (4), 870-881, 2018 | 88 | 2018 |
| Artesunate shows potent anti-tumor activity in B-cell lymphoma TK Våtsveen, MR Myhre, CB Steen, S Wälchli, OC Lingjærde, B Bai, ... Journal of hematology & oncology 11, 1-12, 2018 | 77 | 2018 |
| T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth EM Inderberg, S Wälchli, MR Myhre, S Trachsel, H Almåsbak, G Kvalheim, ... Oncoimmunology 6 (4), e1302631, 2017 | 62 | 2017 |
| NK cells specifically TCR-dressed to kill cancer cells N Mensali, P Dillard, M Hebeisen, S Lorenz, T Theodossiou, MR Myhre, ... EBioMedicine 40, 106-117, 2019 | 61 | 2019 |
| An inducible mouse model of melanoma expressing a defined tumor antigen IJ Huijbers, P Krimpenfort, P Chomez, MA van der Valk, JY Song, ... Cancer research 66 (6), 3278-3286, 2006 | 58 | 2006 |
| Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells JA Kyte, S Aamdal, S Dueland, S Sæbøe-Larsen, EM Inderberg, ... Oncoimmunology 5 (11), e1232237, 2016 | 48 | 2016 |
| Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma H Köksal, P Dillard, SE Josefsson, SM Maggadottir, S Pollmann, A Fåne, ... Blood advances 3 (8), 1230-1243, 2019 | 47 | 2019 |
| Treating osteosarcoma with CAR T cells H Köksal, E Müller, EM Inderberg, Ø Bruland, S Wälchli Scandinavian Journal of Immunology 89 (3), e12741, 2019 | 45 | 2019 |
| Enhancing antitumor immune responses by optimized combinations of cell-penetrating peptide-based vaccines and adjuvants E Belnoue, W Di Berardino-Besson, H Gaertner, S Carboni, ... Molecular Therapy 24 (9), 1675-1685, 2016 | 35 | 2016 |
| Telomerase polypeptide vaccine for treating cancer G Gaudernack, AM Rasmussen, EMI Suso US Patent 9,657,068, 2017 | 34 | 2017 |
| Long-term outcomes of a phase I study with UV1, a second generation telomerase based vaccine, in patients with advanced non-small cell lung cancer PF Brunsvig, TK Guren, M Nyakas, CH Steinfeldt-Reisse, W Rasch, ... Frontiers in Immunology 11, 572172, 2020 | 33 | 2020 |
| Minimal tolerance to a tumor antigen encoded by a cancer-germline gene IJ Huijbers, SM Soudja, C Uyttenhove, M Buferne, EM Inderberg-Suso, ... The Journal of Immunology 188 (1), 111-121, 2012 | 32 | 2012 |
